Revance Therapeutics Inc. (RVNC)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Palo Alto Investors

William Leland Edwards

1,994,905 $50,152 +18% 2.75%
2.
Polar Capital

Brian Ashford-Russell And Tim Woolley

1,115,804 $28,051 -14% 0.2%
3.
Driehaus Capital

Richard Driehaus

583,363 $14,666 -23% 0.3%
4. 315,900 $7,942 +1939% 0%
5. 258,682 $6,503 +1586% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$31.20 900 Director 6,150 2018-03-16 Filing
$31.25 2,250 Director 5,250 2018-03-16 Filing
$27.45 500 Director 20,000 2017-11-07 Filing
$26.95 19,500 Director 19,500 2017-11-07 Filing
$17.74 780 Officer 14,980 2014-12-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$26.15 33,119 Officer, Director 543,803 2020-10-29 Filing
$26.18 33,119 Officer, Director 576,922 2020-09-28 Filing
$15.51 11,613 Officer, Director 151,193 2019-03-18 Filing
$15.48 498 Officer 6,400 2019-03-18 Filing
$17.68 5,446 Officer, Director 168,943 2019-02-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 42,223 $1,061,486 0%
2. 14,879 $374,058 0%
3. 13,943 $350,527 0%
4. 5,446 $137,000 0.08%
5. 4,881,188 $122,713 0%
News See All